Clinical Observation Of Integrated Kangmai Capsule Treating Arteriosclerosis Obliterans

Arteriosclerosis obliterans is a common peripheral vascular disease resulted from arteriosclerosis, which belongs to blood stasis, mortification in traditional Chinese medicine Kangmai capsule is gained in about 20 years, clinical observation by professor Li Linggen. Kangmai capsule has favorable remedial effect in Arteriosclerosis obliterans and other peripheral vascular diseases. The research selected 40-80 years old patients in accord with the ASO diagnostic standard as the samples adopting integrated Kangmai capsule and to therapy ASO so as to study the integrated Chinese and Western Medicine treatment mechanism in treating ASO, analyze and appraise its clinical curative effect synthetically.Method: We select 60 patients treated by integrated Kanmai capsule. And we observed the changes before and after the treatment with the patients symptom, physical sign, blood-fat, ET, TXB₂, NO, 6-K-PGF1a in blood, ect. Results showed integrated Kangmai capsule could obviously lower patients blood-fat, ET, TXB₂, and raise NO, 6-K-PGFla in blood.Conclusion : After treating by integrated Kangmai capsule, interrelated norms to ASO obviously promote. So we can draw a conclusion: This treatment method can be put into practice and its apply should be extended.